{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "PF-04965842",
        "type": {
          "id": "7ceb7332-b2b8-48d2-b63c-b89762b1534c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "fef95107-e638-4148-a3c7-5149319eb824",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "An orally bioavailable small molecule that selectively inhibits JAK1 by blocking the ATP binding site.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "b32746fb-81ce-4c10-972b-a06ed17c9f90",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "76ca3f4c-b84e-4659-8d88-85aa74ce5ffc",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo used in the double-blind maintenance treatment period.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Topical therapy",
        "type": {
          "id": "032e26ef-bbc5-4048-aa77-1da672dcffdf",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "df0a33ff-46f5-4f22-b07e-e6a9d867d1dd",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Topical therapy per local standard of care (SOC) used in combination with PF-04965842 during the rescue period.",
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Emollients",
        "type": {
          "id": "b9cc1991-b46b-406a-9f3f-14f7752edb00",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b2ed106b-4b6d-43d7-b351-33af825a3632",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Non-medicated topical therapies.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Acetylsalicylic acid",
        "type": {
          "id": "95b26737-43cf-41e7-ae95-578a26cba598",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0443335c-ca39-4810-8656-cb55af56c1e6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Low dose (≤100 mg QD) permitted for cardiovascular prophylaxis."
      },
      {
        "id": "int_6",
        "name": "Topical corticosteroids (TCS)",
        "type": {
          "id": "ffed75e9-54eb-4799-a710-616d631ba430",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "ef4118a9-67af-4425-802c-233057c31c10",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Must be washed out during the screening period."
      },
      {
        "id": "int_7",
        "name": "Topical calcineurin inhibitors (TCI)",
        "type": {
          "id": "7bb7a4dd-c03b-4613-b586-de7c36a59333",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "673a26de-1844-4c21-8210-410ce7d6d173",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Must be washed out during the screening period."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "PF-04965842 tablets",
        "administrableDoseForm": {
          "id": "3d9d03dc-a111-4c3f-8e7e-22ff29f686a5",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "48cb3863-ae82-4321-8582-4077ffac3d13",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "bc66e392-700f-4b5b-a7ae-8f00551581da",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Pfizer"
      },
      {
        "id": "prod_2",
        "name": "PF-04965842 tablets",
        "administrableDoseForm": {
          "id": "8fb52daa-0b75-4a39-92db-2f0268d567f0",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "6c2396d2-d22c-48a2-9fa2-09acaff15dad",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "bab6e9bc-6333-45c2-9f81-99c05a3b168e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "200 mg",
        "manufacturer": "Pfizer"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Open-label Run-in Induction",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "12 weeks"
      },
      {
        "id": "admin_2",
        "name": "Double-blind Maintenance (High Dose)",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "40 weeks"
      },
      {
        "id": "admin_3",
        "name": "Double-blind Maintenance (Low Dose)",
        "instanceType": "Administration",
        "dose": "100 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "40 weeks"
      },
      {
        "id": "admin_4",
        "name": "Open-label Rescue Treatment",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "12 weeks"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "PF-04965842",
        "instanceType": "Substance",
        "description": "Selective Janus kinase 1 (JAK1) inhibitor"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "ePRO device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 7,
      "productCount": 2,
      "deviceCount": 1
    }
  },
  "rawResponse": [
    {
      "interventions": [
        {
          "name": "PF-04965842",
          "role": "Investigational Product",
          "description": "An orally bioavailable small molecule that selectively inhibits JAK1 by blocking the ATP binding site."
        },
        {
          "name": "Placebo",
          "role": "Placebo",
          "description": "Matching placebo used in the double-blind maintenance treatment period."
        },
        {
          "name": "Topical therapy",
          "role": "Rescue Medication",
          "description": "Topical therapy per local standard of care (SOC) used in combination with PF-04965842 during the rescue period."
        },
        {
          "name": "Emollients",
          "role": "Concomitant Medication",
          "description": "Non-medicated topical therapies."
        },
        {
          "name": "Acetylsalicylic acid",
          "role": "Concomitant Medication",
          "description": "Low dose (≤100 mg QD) permitted for cardiovascular prophylaxis."
        },
        {
          "name": "Topical corticosteroids (TCS)",
          "role": "Prior Medication",
          "description": "Must be washed out during the screening period."
        },
        {
          "name": "Topical calcineurin inhibitors (TCI)",
          "role": "Prior Medication",
          "description": "Must be washed out during the screening period."
        }
      ],
      "products": [
        {
          "name": "PF-04965842 tablets",
          "doseForm": "Tablet",
          "strength": "100 mg",
          "manufacturer": "Pfizer"
        },
        {
          "name": "PF-04965842 tablets",
          "doseForm": "Tablet",
          "strength": "200 mg",
          "manufacturer": "Pfizer"
        }
      ],
      "substances": [
        {
          "name": "PF-04965842",
          "description": "Selective Janus kinase 1 (JAK1) inhibitor"
        }
      ],
      "administrations": [
        {
          "name": "Open-label Run-in Induction",
          "dose": "200 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "12 weeks"
        },
        {
          "name": "Double-blind Maintenance (High Dose)",
          "dose": "200 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "40 weeks"
        },
        {
          "name": "Double-blind Maintenance (Low Dose)",
          "dose": "100 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "40 weeks"
        },
        {
          "name": "Open-label Rescue Treatment",
          "dose": "200 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "12 weeks"
        }
      ],
      "devices": [
        {
          "name": "ePRO device",
          "manufacturer": "Not specified",
          "purpose": "Electronic tablet used for daily collection of Pruritus NRS and PSAAD data."
        }
      ]
    }
  ]
}